132 related articles for article (PubMed ID: 26346266)
1. Tenofovir-induced severe hepatitis in occult hepatitis B reactivation.
Habib G; Nashashibi M
Dig Liver Dis; 2015 Oct; 47(10):898-9. PubMed ID: 26346266
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma.
Liu WP; Wang XP; Zheng W; Ping LY; Zhang C; Wang GQ; Song YQ; Zhu J
Leuk Lymphoma; 2016; 57(6):1355-62. PubMed ID: 26727044
[TBL] [Abstract][Full Text] [Related]
3. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
4. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
Masarone M; De Renzo A; La Mura V; Sasso FC; Romano M; Signoriello G; Rosato V; Perna F; Pane F; Persico M
BMC Gastroenterol; 2014 Feb; 14():31. PubMed ID: 24533834
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen seroreversion in a T-cell lymphoma patient.
Chen HW; Lin SA; Lin HC; Kao WY
J BUON; 2011; 16(2):374-6. PubMed ID: 21766517
[No Abstract] [Full Text] [Related]
6. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
[No Abstract] [Full Text] [Related]
7. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
Uchiyama M; Tamai Y; Ikeda T
Int J Infect Dis; 2010 Mar; 14(3):e265-6. PubMed ID: 19665406
[No Abstract] [Full Text] [Related]
8. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma resembling a metastatic liver tumour.
Saitoh Y; Gotoh M; Katagiri S; Ohyashiki K
Br J Haematol; 2015 Jan; 168(1):1. PubMed ID: 25312576
[No Abstract] [Full Text] [Related]
10. Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study.
Huang HH; Hsiao FY; Chen HM; Wang CY; Ko BS
Br J Haematol; 2021 Jan; 192(1):110-118. PubMed ID: 33131074
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.
Li X; Lin Q; Dong M; Wen JY; Wei L; Ma XK; Chen ZH; Wu XY
Leuk Lymphoma; 2010 Sep; 51(9):1678-85. PubMed ID: 20807095
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N
J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949
[TBL] [Abstract][Full Text] [Related]
13. Intravascular large B-cell lymphoma--a diagnostic dilemma.
Ramkumar B; Hutchison R; Khadim H; Gajra A
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
[No Abstract] [Full Text] [Related]
14. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
Lai S; Venugopal P; Leslie W
Clin Adv Hematol Oncol; 2012 Feb; 10(2):134-6. PubMed ID: 22402359
[No Abstract] [Full Text] [Related]
15. Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Öneç B; Öneç K; Esbah AÜ; Esbah O
Turk J Haematol; 2016 Dec; 33(4):362-363. PubMed ID: 27095140
[No Abstract] [Full Text] [Related]
16. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
[TBL] [Abstract][Full Text] [Related]
17. Case 3: Hepatosplenomegaly in a 2-year-old Boy.
Ramachandran R
Pediatr Rev; 2015 Jun; 36(6):265-7. PubMed ID: 26034258
[No Abstract] [Full Text] [Related]
18. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Dillon R; Hirschfield GM; Allison ME; Rege KP
BMJ; 2008 Jul; 337():a423. PubMed ID: 18595895
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.
Crespo J; Esteban R; Torres C; Oyagüez I; Casado MÁ; Buti M
Rev Esp Enferm Dig; 2017 Sep; 109(9):619-626. PubMed ID: 28648087
[TBL] [Abstract][Full Text] [Related]
20. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
